Guidelines for diagnosis and management of cardiovascular sequelae in kawasaki disease (JCS 2013)- Digest version-

Circulation Journal

Volumn 78, Issue 10, 2014, Pages 2521-2562

 

^a Cardiac Transplantation Committee of the Japanese Circulation Society   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOSCLEROSIS; CORONARY ARTERY ANEURYSM; CORONARY HEMODYNAMICS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; EXERCISE; FOLLOW UP; GENETIC TRAIT; HEART CATHETERIZATION; HEART REHABILITATION; HUMAN; LIFESTYLE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDIAL DISEASE; NOTE; PRACTICE GUIDELINE; VACCINATION; COMPLICATION; GENETICS; HEART DISEASES; METABOLISM; PATHOLOGY;

HEART DISEASES; HUMANS; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 84908256059     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-66-0096     Document Type: Note

References (267)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Japanese Journal of Allergology 1967; 16: 178-222 (in Japanese).
2. Guidelines for Diagnosis and Treatment of Cardiovascular Diseases (2001-2002 Joint Working Groups Report). Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2003). Circ J 2003; 67 (Suppl 4): 1111-1174 (in Japanese).
3. Guidelines for Diagnosis and Treatment of Cardiovascular Diseases (2007 Joint Working Groups Report). Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008). http://www.j-circ.or.jp/guideline/pdf/JCS2008_ogawasy_h.pdf (in Japanese) (available January 2013).
4. Nakamura Y, Yashiro M, Uehara R, Sadakane A, Tsuboi S, Aoyama Y, et al. Epidemiologic features of Kawasaki disease in Japan: Results of the 2009-2010 nationwide survey. J Epidemiol 2012; 22: 216-221.
5. Kawasaki Disease Study Group of the Ministry of Health, Labour and Welfare. Guidelines for the Diagnosis of Kawasaki Disease (MCLS, infantile acute febrile mucocutaneous lymph node syndrome), fifth revision. J Jpn Pediatr Soc 2002; 106: 836-837 (in Japanese).
6. Burgner D, Davila S, Breunis WB, Ng SB, Li Y, Bonnard C, et al; International Kawasaki Disease Genetics Consortium. A genomewide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet 2009; 5: 1000319, doi:10.1371/journal.pgen.1000319.
7. Kim JJ, Hong YM, Sohn S, Jang GY, Ha KS, Yun SW, et al; Korean Kawasaki Disease Genetics Consortium. A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease. Hum Genet 2011; 129: 487-495.
8. Tsai FJ, Lee YC, Chang JS, Huang LM, Huang FY, Chiu NC, et al. Identification of novel susceptibility Loci for kawasaki disease in a Han chinese population by a genome-wide association study. PLoS One 2011; 6: 16853, doi:10.1371/journal.pone.0016853.
9. Khor CC, Davila S, Breunis WB, Lee YC, Shimizu C, Wright VJ, et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet 2011; 43: 1241-1246.
10. Lee YC, Kuo HC, Chang JS, Chang LY, Huang LM, Chen MR, et al. Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet 2012; 44: 522-525.
11. Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai M, Hamada H, et al; Japan Kawasaki Disease Genome Consortium; US Kawasaki Disease Genetics Consortium. A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet 2012; 44: 517-521.
12. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 2008; 40: 35-42.
13. Onouchi Y, Ozaki K, Buns JC, Shimizu C, Hamada H, Honda T, et al. Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum Mol Genet 2010; 19: 2898-2906.
14. Khor CC, Davila S, Shimizu C, Sheng S, Matsubara T, Suzuki Y, et al; US and International Kawasaki Disease Genetics Consortia. Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease. J Med Genet 2011; 48: 467-472.
15. Asai T. Severity assessment of Kawasaki disease. Acta Paediatr Jpn Overseas Ed 1983; 25: 170-175.
16. Iwasa M, Sugiyama K, Ando T, Nomura H, Katoh T, Wada Y. Selection of high-risk children for immunoglobulin therapy in Kawasaki disease. Prog Clin Biol Res 1987; 250: 543-544.
17. Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 1991; 33: 805-810.
18. Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 2006; 113: 2606-2612.
19. Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 2006; 149: 237-240.
20. Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, et al. Prediction of nonresponsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 2007; 166: 131-137.
21. Kobayashi T, Inoue Y, Tamura K, Morikawa A, Kobayashi T. External validation of a scoring system to predict resistance to intravenous immunoglobulin. J Pediatr 2007; 150: e37; author reply 38, doi:10.1016/j.jpeds.2006.12.036.
22. Seki M, Kobayashi T, Kobayashi T, Morikawa A, Otani T, Takeuchi K, et al. External validation of a risk score to predict intravenous immunoglobulin resistance in patients with Kawasaki disease. Pediatr Infect Dis J 2011; 30: 145-147.
23. Sleeper LA, Minich LL, McCrindle BM, Li JS, Mason W, Colan SD, et al; Pediatric Heart Network Investigators. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr 2011; 158: 831-835.e3, doi:10. 1016/j.jpeds.2010.10.031.
24. Sudo D, Monobe Y, Yashiro M, Mieno MN, Uehara R, Tsuchiya K, et al. Coronary artery lesions of incomplete Kawasaki disease: A nationwide survey in Japan. Eur J Pediatr 2012; 171: 651-656.
25. Manlhiot C, Christie E, McCrindle BW, Rosenberg H, Chahal N, Yeung RS. Complete and incomplete Kawasaki disease: Two sides of the same coin. Eur J Pediatr 2012; 171: 657-662.
26. Sonobe T, Kiyosawa N, Tsuchiya K, Aso S, Imada Y, Imai Y, et al. Prevalence of coronary artery abnormality in incomplete Kawasaki disease. Pediatr Int 2007; 49: 421-426.
27. Ha KS, Jang G, Lee J, Lee K, Hong Y, Son C, et al. Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: A meta-analysis. Eur J Pediatr 2013; 172: 343-349.
28. Kuo HC, Yang KD, Juo SH, Liang CD, Chen WC, Wang YS, et al. ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population. PLoS One 2011; 6: 17370, doi:10.1371/journal.pone.0017370.
29. Lin MT, Wang JK, Yeh JI, Sun LC, Chen PL, Wu JF, et al. Clinical implication of the c allele of the ITPKC gene SNP rs28493229 in Kawasaki disease: Association with disease susceptibility and BCG scar reactivation. Pediatr Infect Dis J 2011; 30: 148-152.
30. Kuo HC, Yu HR, Juo SH, Yang KD, Wang YS, Liang CD, et al. CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children. J Hum Genet 2011; 56: 161-165.
31. Takahashi K, Oharaseki T, Naoe S, Wakayama M, Yokouchi Y. Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr Int 2005; 47: 305-310.
32. Masuda H, Naoe S, Tanaka N. The pathology of coronary arteries in Kawasaki disease (MCLS): A consideration of the relationship between coronary arteritis and the development of aneurysms. The Journal of Japanese College of Angiology 1981; 21: 899-912 (in Japanese).
33. Terminology Committee of the Japanese Society of Kawasaki Disease. Draft rules for the terminology of Kawasaki disease.http://www.jskd.jp/info/pdf/yougo201007.pdf (in Japanese).
34. Sasaguri Y, Kato H. Regression of aneurysms in Kawasaki disease: A pathological study. J Pediatr 1982; 100: 225-231.
35. Suzuki A, Yamagishi M, Kimura K, Sugiyama H, Arakaki Y, Kamiya T, et al. Functional behavior and morphology of the coronary artery wall in patients with Kawasaki disease assessed by intravascular ultrasound. J Am Coll Cardiol 1996; 27: 291-296.
36. Mitani Y, Okuda Y, Shimpo H, Uchida F, Hamanaka K, Aoki K, et al. Impaired endothelial function in epicardial coronary arteries after Kawasaki disease. Circulation 1997; 96: 454-461.
37. Sugimura T, Kato H, Inoue O, Fukuda T, Sato N, Ishii M, et al. Intravascular ultrasound of coronary arteries in children: Assessment of the wall morphology and the lumen after Kawasaki disease. Circulation 1994; 89: 258-265.
38. Yamakawa R, Ishii M, Sugimura T, Akagi T, Eto G, Iemura M, et al. Coronary endothelial dysfunction after Kawasaki disease: Evaluation by intracoronary injection of acetylcholine. J Am Coll Cardiol 1998; 31: 1074-1080.
39. Takahashi K, Oharaseki T, Naoe S. Pathological study of postcoronary arteritis in adolescents and young adults: With reference to the relationship between sequelae of Kawasaki disease and atherosclerosis. Pediatr Cardiol 2001; 22: 138-142.
40. Tanaka N, Naoe S, Masuda H, Ueno T. Pathological study of sequelae of Kawasaki disease (MCLS): With special reference to the heart and coronary arterial lesions. Acta Pathol Jpn 1986; 36: 1513-1527.
41. Negoro N, Nariyama J, Nakagawa A, Katayama H, Okabe T, Hazui H, et al. Successful catheter interventional therapy for acute coronary syndrome secondary to Kawasaki disease in young adults. Circ J 2003; 67: 362-365.
42. Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T, et al. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: Immunohistochemical study. Circulation 2000; 101: 2935-2941.
43. Takahasi K, Shibuya H, Atobe T, Naoe S, Tanaka N. Histopathological study of Kawasaki disease in patients who died of intercurrent diseases. Prog Med 1987; 7: 21-25 (in Japanese).
44. Kikuchi F, Mori N, Naoe S, Makita J. A case of death due to bronchial asthma attack in a patient with a history of typical Kawasaki disease who has no evidence of current or previous arteritis at autopsy. Prog Med 1987; 7: 131-137 (in Japanese).
45. Harada M, Yokouchi Y, Oharaseki T, Matsui K, Tobayama H, Tanaka N, et al. Histopathological characteristics of myocarditis in acute-phase Kawasaki disease. Histopathology 2012; 61: 1156-1167.
46. Yonesaka S, Nakada T, Sunagawa Y, Tomimoto K, Naka S, Takahashi T, et al. Endomyocardial biopsy in children with Kawasaki disease. Acta Paediatr Jpn 1989; 31: 706-711.
47. Takahashi K, Shibuya K, Masuda H, Tanaka N. Pathology of cardiac sequelae of Kawasaki disease. The Journal of Japanese College of Angiology 1989; 29: 461-469 (in Japanese).
48. Amano S, Hazama F, Kubagawa H, Tasaka K, Haebara H, Hamashima Y. General pathology of Kawasaki disease: On the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn 1980; 30: 681-694.
49. Landing BH, Larson EJ. Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome). Am J Cardiovasc Pathol 1987; 1: 218-229.
50. Takahashi K, Oharaseki T, Yokouchi Y, Hiruta N, Naoe S. Kawasaki disease as a systemic vasculitis in childhood. Ann Vasc Dis 2010; 3: 173-181.
51. Takahashi K, Oharaseki T, Yokouchi Y. Aneurysms due to Kawasaki disease during adulthood: Transition from acute phase coronary arteritis to remote phase arteriosclerotic lesions and a consideration of differences from arteriosclerosis in adults without a history of Kawasaki disease. Vascular Med 2010; 6: 22-26 (in Japanese).
52. Ogawa S, Ohkubo T, Fukazawa R, Kamisago M, Kuramochi Y, Uchikoba Y, et al. Estimation of myocardial hemodynamics before and after intervention in children with Kawasaki disease. J Am Coll Cardiol 2004; 43: 653-661.
53. Donohue TJ, Kern MJ, Aguirre FV, Bach RG, Wolford T, Bell CA, et al. Assessing the hemodynamic significance of coronary artery stenoses: Analysis of translesional pressure-flow velocity relations in patients. J Am Coll Cardiol 1993; 22: 449-458.
54. Ofili EO, Kern MJ, Labovitz AJ, St Vrain JA, Segal J, Aguirre FV, et al. Analysis of coronary blood flow velocity dynamics in angiographically normal and stenosed arteries before and after endolumen enlargement by angioplasty. J Am Coll Cardiol 1993; 21: 308-316.
55. Segal J, Kern MJ, Scott NA, King SB, Doucette JW, Heuser RR, et al. Alterations of phasic coronary artery flow velocity in humans during percutaneous coronary angioplasty. J Am Coll Cardiol 1992; 20: 276-286.
56. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993; 87: 1354-1367.
57. Ogawa S. Rheologic and hemodynamic characteristics of coronary arteries. J Jpn Pediatr Soc 2009; 113: 1769-1778 (in Japanese).
58. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined: A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
59. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-STsegment elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2000; 36: 970-1062.
60. Okamoto F, Sohmiya K, Ohkaru Y, Kawamura K, Asayama K, Kimura H, et al. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction: Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin Chem Lab Med 2000; 38: 231-238.
61. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease: The FRISC study group. Circulation 1996; 93: 1651-1657.
62. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med 1996; 335: 1333-1341.
63. Isobe M, Nagai R, Ueda S, Tsuchimochi H, Nakaoka H, Takaku F, et al. Quantitative relationship between left ventricular function and serum cardiac myosin light chain I levels after coronary reperfusion in patients with acute myocardial infarction. Circulation 1987; 76: 1251-1261.
64. Khreiss T, József L, Potempa LA, Filep JG. Opposing effects of C-reactive protein isoforms on shear-induced neutrophil-platelet adhesion and neutrophil aggregation in whole blood. Circulation 2004; 110: 2713-2720.
65. Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M, et al. Elevated levels of highsensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: Association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 2005; 111: 38-43.
66. Yonesaka S, Takahashi T, Sato T, Eto S, Ohtani K, Kitagawa Y, et al. Ongoing myocardial damage in infants and children with Kawasaki disease. Respiration & Circulation 2010; 58: 1273-1279 (in Japanese).
67. Borzutzky A, Gutiérrez M, Talesnik E, Godoy I, Kraus J, Hoyos R, et al. High sensitivity C-reactive protein and endothelial function in Chilean patients with history of Kawasaki disease. Clin Rheumatol 2008; 27: 845-850.
68. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: The Bogalusa Heart Study. N Engl J Med 1998; 338: 1650-1656.
69. Okada T, Murata M, Yamauchi K, Harada K. New criteria of normal serum lipid levels in Japanese children: The nationwide study. Pediatr Int 2002; 44: 596-601.
70. Japan Atherosclerosis Society. Japan Atherosclerosis Society (JAS) Guidelines for Diagnosis and Treatment of Atherosclerotic Cardiovascular Diseases, 2002. 2002: 5-7 (in Japanese).
71. Japan Atherosclerosis Society. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases, 2007. 2007: 11-13 (in Japanese).
72. Ou CY, Tseng YF, Lee CL, Chiou YH, Hsieh KS. Significant relationship between serum high-sensitivity C-reactive protein, highdensity lipoprotein cholesterol levels and children with Kawasaki disease and coronary artery lesions. J Formos Med Assoc 2009; 108: 719-724.
73. Boers GH, Smals AG, Trijbels FJ, Fowler B, Bakkeren JA, Schoonderwaldt HC, et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985; 313: 709-715.
74. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 338: 1042-1050.
75. Ohzeki T, Nakagawa Y, Nakanishi T, Fujisawa Y, Sai S. Diagnostic criteria for metabolic syndrome in Japanese children: A cohort study to establish the concept, pathophysiology, and diagnostic criteria of metabolic syndrome in children and design effective interventions: An MHLW grant research project for cardiovascular disease and lifestyle-related diseases led by Ohzeki T. A final report in 2005-2007. 2008: 89-91 (in Japanese).
76. Council on Cardiovascular Disease in the Young; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease; American Heart Association: Diagnostic guidelines for Kawasaki disease. Circulation 2001; 103: 335-336.
77. Ichida F, Fatica NS, O’Loughlin JE, Snyder MS, Ehlers KH, Engle MA. Correlation of electrocardiographic and echocardiographic changes in Kawasaki syndrome. Am Heart J 1988; 116: 812-819.
78. Okagawa H, Kondo M, Okuno M, Fujino H, Nishijima S. QT duration in the acute phase of Kawasaki disease. Prog Med 1997; 17: 1761-1764 (in Japanese).
79. Onouchi Z, Shimazu S, Tamiya H. The second report on abnormal T waves on ECG in patients with Kawasaki disease: Left ventricular asynergy in short-axis two-dimensional echographic images. J Jpn Pediatr Soc 1986; 90: 827-831 (in Japanese).
80. Gravel H, Dahdah N, Fournier A, Mathieu MÈ, Curnier D. Ventricular repolarisation during exercise challenge occurring late after Kawasaki disease. Pediatr Cardiol 2012; 33: 728-734.
81. Osada M, Tanaka Y, Komai T, Maeda Y, Kitano M, Komori S, et al. Coronary arterial involvement and QT dispersion in Kawasaki disease. Am J Cardiol 1999; 84: 466-468.
82. Okuyama J, Osada M, Sugiyama H, Komori S, Ozaki Y. QT dispersion and its longitudinal change in Kawasaki disease. Japanese Journal of Electrocardiology 2001; 21: 800-804 (in Japanese).
83. Nakata T. Premature ventricular contraction in remote-phase Kawasaki disease. Medical Journal Aomori 1995; 40: 98-103 (in Japanese).
84. Nakanishi T, Takao A, Kondoh C, Nakazawa M, Hiroe M, Matsumoto Y. ECG findings after myocardial infarction in children after Kawasaki disease. Am Heart J 1988; 116: 1028-1033.
85. Hamaoka K, Kamiya Y, Sakata K, Fukumochi Y, Ohmochi Y. Coronary reserve in children of Kawasaki disease with ischemic findings on exercise ECG and myocardial SPECT but angiographically no stenotic lesion. Evaluation of coronary hemodynamics and myocardial metabolism during atrial pacing. J Jpn Pediatr Soc 1991; 95: 145-151 (in Japanese).
86. Matsuda M, Shimizu T, Oouchi H, Saito S, Kawade M, Arakaki Y, et al. Diagnosis of myocardial ischemia using body surface electrocardiographic mapping with intravenous dipyridamole in children who have a history of Kawasaki disease. J Jpn Pediatr Soc 1995; 99: 1618-1627 (in Japanese).
87. Takechi N, Seki T, Ohkubo T, Ogawa S. Dobutamine stress surface mapping of myocardial ischemia in Kawasaki disease. Pediatr Int 2001; 43: 218-225.
88. Seki T, Zhang J, Ogawa S, Hirayama T. Dobutamine stress body surface mapping in Kawasaki disease. Journal of Nippon Medical School 1994; 61: 610-619 (in Japanese).
89. Shiono J, Horigome H, Matsui A, Terada Y, Watanabe S, Miyashita T, et al. Evaluation of myocardial ischemia in Kawasaki disease using an isointegral map on magnetocardiogram. Pacing Clin Electrophysiol 2002; 25: 915-921.
90. Sumitomo N, Karasawa K, Taniguchi K, Ichikawa R, Fukuhara J, Abe O, et al. Association of sinus node dysfunction, atrioventricular node conduction abnormality and ventricular arrhythmia in patients with Kawasaki disease and coronary involvement. Circ J 2008; 72: 274-280.
91. Hamamoto K, Oku I, Yamato K. Evaluation of intracardiac conduction delay in acute phase of Kawasaki disease by signal averaged electrocardiogram. Heart 1998; 30: 21-27 (in Japanese).
92. Tsuchida A, Ito S, Oka R, Saito T, Yoshioka I. Recording by signalaveraged electrocardiogram in patients with Kawasaki disease. J Jpn Pediatr Soc 1990; 94: 1168-1173 (in Japanese).
93. Dahdah NS, Jaeggi E, Fournier A. Electrocardiographic depolarization and repolarization: Long-term after Kawasaki disease. Pediatr Cardiol 2002; 23: 513-517.
94. Kuramochi Y, Takechi N, Ohkubo T, Ogawa S. Longitudinal estimation of signal-averaged electrocardiograms in patients with Kawasaki disease. Pediatr Int 2002; 44: 12-17.
95. Takeuchi M, Matsushita A, Tsuda E, Kurotobi S, Kogaki S. Clinical assessment of ventricular late potential in children with Kawasaki disease: Frequency analysis and its clinical significance. Prog Med 1994; 14: 1828-1832 (in Japanese).
96. Ogawa S, Nagai Y, Zhang J, Yuge K, Hino Y, Jimbo O, et al. Evaluation of myocardial ischemia and infarction by signal-averaged electrocardiographic late potentials in children with Kawasaki disease. Am J Cardiol 1996; 78: 175-181.
97. Genma Y, Ogawa S, Zhang J, Yamamoto M. Evaluation of myocardial ischemia in Kawasaki disease by dobutamine stress signalaveraged ventricular late potentials. Cardiovasc Res 1997; 36: 323-329.
98. Tanaka N, Ueno T, Naoe S, Masuda H. Kawasaki disease: Pathological features and sequelae of arteritis. Japanese Journal of Clinical Medicine 1983; 41: 2008-2016 (in Japanese).
99. Nakada T, Yonesaka S, Sunagawa Y, Tomimoto K, Takahashi T, Matsubara T, et al. Coronary arterial calcification in Kawasaki disease. Acta Paediatr Jpn 1991; 33: 443-449.
100. Fuse S, Kobayashi T, Arakaki Y, Ogawa S, Katoh H, Sakamoto N, et al. Standard method for ultrasound imaging of coronary artery in children. Pediatr Int 2010; 52: 876-882.
101. Newburger JW, Sanders SP, Burns JC, Parness IA, Beiser AS, Colan SD. Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin. Circulation 1989; 79: 1237-1246.
102. Yanagisawa M, Yano S, Shiraishi H, Nakajima Y, Fujimoto T, Itoh K. Coronary aneurysms in Kawasaki disease: Follow-up observation by two-dimensional echocardiography. Pediatr Cardiol 1985; 6: 11-16.
103. Minich LL, Tani LY, Pagotto LT, Young PC, Etheridge SP, Shaddy RE. Usefulness of echocardiography for detection of coronary artery thrombi in patients with Kawasaki disease. Am J Cardiol 1998; 82: 1143-1146, A1110.
104. Miyashita M, Karasawa K, Taniguchi K, Kanamaru H, Ayusawa M, Sumitomo N, et al. Usefulness of real-time 3-dimensional echocardiography for the evaluation of coronary artery morphology in patients with Kawasaki disease. J Am Soc Echocardiogr 2007; 20: 930-933.
105. Nakano H, Saito A, Ueda K, Tsuchitani Y. Valvular lesions complicating Kawasaki disease: A Doppler echocardiographic evaluation. J Cardiogr 1986; 16: 363-371 (in Japanese).
106. Takeuchi D, Saji T, Takatsuki S, Fujiwara M. Abnormal tissue Doppler images are associated with elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease. Circ J 2007; 71: 357-362.
107. Noto N, Ayusawa M, Karasawa K, Yamaguchi H, Sumitomo N, Okada T, et al. Dobutamine stress echocardiography for detection of coronary artery stenosis in children with Kawasaki disease. J Am Coll Cardiol 1996; 27: 1251-1256.
108. Ishii M, Himeno W, Sawa M, Iemura M, Furui J, Muta H, et al. Assessment of the ability of myocardial contrast echocardiography with harmonic power Doppler imaging to identify perfusion abnormalities in patients with Kawasaki disease at rest and during dipyridamole stress. Pediatr Cardiol 2002; 23: 192-199.
109. Hijazi ZM, Udelson JE, Snapper H, Rhodes J, Marx GR, Schwartz SL, et al. Physiologic significance of chronic coronary aneurysms in patients with Kawasaki disease. J Am Coll Cardiol 1994; 24: 1633-1638.
110. Paridon SM, Galioto FM, Vincent JA, Tomassoni TL, Sullivan NM, Bricker JT. Exercise capacity and incidence of myocardial perfusion defects after Kawasaki disease in children and adolescents. J Am Coll Cardiol 1995; 25: 1420-1424.
111. Miyagawa M, Mochizuki T, Murase K, Tanada S, Ikezoe J, Sekiya M, et al. Prognostic value of dipyridamole-thallium myocardial scintigraphy in patients with Kawasaki disease. Circulation 1998; 98: 990-996.
112. Kondo C, Hiroe M, Nakanishi T, Takao A. Detection of coronary artery stenosis in children with Kawasaki disease: Usefulness of pharmacologic stress 201Tl myocardial tomography. Circulation 1989; 80: 615-624.
113. Ogawa S, Fukazawa R, Ohkubo T, Zhang J, Takechi N, Kuramochi Y, et al. Silent myocardial ischemia in Kawasaki disease: Evaluation of percutaneous transluminal coronary angioplasty by dobutamine stress testing. Circulation 1997; 96: 3384-3389.
114. Karasawa K, Ayusawa M, Noto N, Yamaguchi H, Okada T, Harada K. The dobutamine stress T1-201 myocardial single photon emission computed tomography for coronary artery stenosis caused by Kawasaki disease. Ped Cardiol Card Surg 1994; 9: 723-733 (in Japanese).
115. Prabhu AS, Singh TP, Morrow WR, Muzik O, Di Carli MF. Safety and efficacy of intravenous adenosine for pharmacologic stress testing in children with aortic valve disease or Kawasaki disease. Am J Cardiol 1999; 83: 284-286, A286.
116. Kinoshita S, Suzuki S, Shindo A, Watanage K, Yamashita S. The accuracy and side effects of pharmacologic stress Thallium myocardial scintigraphy with adenosine triphosphate disodium (ATP) infusion in the diagnosis of coronary artery disease. The Japanese Journal of Nuclear Medicine 1994; 31: 935-941 (in Japanese).
117. Germano G, Erel J, Lewin H, Kavanagh PB, Berman DS. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99 m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1997; 30: 1360-1367.
118. Johnson LL, Verdesca SA, Aude WY, Xavier RC, Nott LT, Campanella MW, et al. Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms. J Am Coll Cardiol 1997; 30: 1641-1648.
119. Ishikawa Y, Fujiwara M, Ono Y, Tsuda E, Matsubara T, Furukawa S, et al. Exercise-or dipyridamoleloaded QGS is useful to evaluate myocardial ischemia and viability in the patients with a history of Kawasaki disease. Pediatr Int 2005; 47: 505-511.
120. Karasawa K, Miyashita M, Taniguchi K, Kanamaru H, Ayusawa M, Noto N, et al. Detection of myocardial contractile reserve by low-dose dobutamine quantitative gated single-photon emission computed tomography in patients with Kawasaki disease and severe coronary artery lesions. Am J Cardiol 2003; 92: 865-868.
121. Karasawa K, Ayusawa M, Noto N, Sumitomo N, Okada T, Harada K. Optimum protocol of technetium-99 m tetrofosmin myocardial perfusion imaging for the detection of coronary stenosis lesions in Kawasaki disease. J Cardiol 1997; 30: 331-339 (in Japanese).
122. Monzen H, Hara M, Hirata M, Nakanishi A, Ogasawara M, Suzuki T, et al. Exploring a technique for reducing the influence of scattered rays from surrounding organs to the heart during myocardial perfusion scintigraphy with technetium-99 m sestamibi and technetium-99 m tetrofosmin. Ann Nucl Med 2006; 20: 705-710.
123. Karasawa K, Ayusawa M, Ymasita T. Pharmacologic stress myocardial perfusion imaging for the detection of coronary stenotic lesions due to Kawasaki disease: Comparison of dobutamine and adenosine triphosphate disodium. In: Kato H, editor. Kawasaki disease: Proceedings of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, 22-25 May 1995. Elsevier 1995: 472-478.
124. Yamazaki J, Nishimura T, Nishimura S, Kajiya T, Kojima K, Kato K. The Diagnostic Value for Ischemic Heart Disease of Thallium-201 Myocardial Scintigraphy by Intravenous Infusion of SUNY4001 (Adenosine): The Report of Clinical Trial at Multi-Center: Phase III. The Japanese Journal of Nuclear Medicine 2004; 41: 133-142 (in Japanese).
125. Subcommittee for Standardization of Radionuclide Imaging, Medical and Pharmaceutical Committee for the Japan Radioisotope Association. Recommendations for a pediatric dose in nuclear imaging. Japan Radioisotope Association. Radioisotopes 1988; 37: 627-632 (in Japanese).
126. Guidelines for Diagnosis and Treatment of Cardiovascular Diseases (2010-2011 Joint Working Groups Report). Guidelines for Drug Therapy in Pediatric Patients with Cardiovascular Diseases (JCS 2012). Guidelines for Diagnosis and Treatment of Cardiovascular Diseases 2012: 89-301 (in Japanese).
127. Lassmann M, Biassoni L, Monsieurs M, Franzius C, Jacobs F; EANM Dosimetry and Paediatrics Committees. The new EANM paediatric dosage card. Eur J Nucl Med Mol Imaging 2007; 34: 796-798.
128. Pediatric Nuclear Medicine Practice Committee of the Japanese Society of Nuclear Medicine. Consensus guidelines for nuclear medicine procedures for children, 2013 (in Japanese).
129. Kanamaru H, Sato Y, Takayama T, Ayusawa M, Karasawa K, Sumitomo N, et al. Assessment of coronary artery abnormalities by multislice spiral computed tomography in adolescents and young adults with Kawasaki disease. Am J Cardiol 2005; 95: 522-525.
130. Kanamaru H, Kimijima T, Mugishima H. Cardiovascular imaging: Cardiac CT. Journal of Japanese Society of Pediatric Radiology 2011; 27: 106-117 (in Japanese).
131. Liu X, Zhao X, Huang J, Francois CJ, Tuite D, Bi X, et al. Comparison of 3D free-breathing coronary MR angiography and 64-MDCT angiography for detection of coronary stenosis in patients with high calcium scores. AJR Am J Roentgenol 2007; 189: 1326-1332.
132. Ozgun M, Rink M, Hoffmeier A, Botnar RM, Heindel W, Fischbach R, et al. Intraindividual comparison of 3D coronary MR angiography and coronary CT angiography. Acad Radiol 2007; 14: 910-916.
133. Kanamaru H, Karasawa K, Ichikawa R, Abe O, Miyashita M, Taniguchi K, et al. Advantages of multislice spiral computed tomography for evaluation of serious coronary complications after Kawasaki disease. J Cardiol 2007; 50: 21-27 (in Japanese).
134. Suzuki A, Takemura A, Inaba R, Sonobe T, Tsuchiya K, Korenaga T. Magnetic resonance coronary angiography to evaluate coronary arterial lesions in patients with Kawasaki disease. Cardiol Young 2006; 16: 563-571.
135. Takemura A, Suzuki A, Inaba R, Sonobe T, Tsuchiya K, Omuro M, et al. Utility of coronary MR angiography in children with Kawasaki disease. AJR Am J Roentgenol 2007; 188: W534-W539.
136. Botnar RM, Kim WY, Börnert P, Stuber M, Spuentrup E, Manning WJ. 3D coronary vessel wall imaging utilizing a local inversion technique with spiral image acquisition. Magn Reson Med 2001; 46: 848-854.
137. Fayad ZA, Fuster V, Fallon JT, Jayasundera T, Worthley SG, Helft G, et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 2000; 102: 506-510.
138. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-1453.
139. Katsumata N, Suzuki A, Takemura A, Kitatsume T, Inaba R, Korenaga T, et al. Imaging of recanalized vessels and evaluation of myocardial disorder with MR coronary angiography. Prog Med 2007; 27: 1574-1578 (in Japanese).
140. Kato H, Ichinose E, Kawasaki T. Myocardial infarction in Kawasaki disease: Clinical analyses in 195 cases. J Pediatr 1986; 108: 923-927.
141. Suzuki A, Kamiya T, Tsuda E, Tsukano S. Natural history of coronary arterial lesions in Kawasaki disease. Prog Pediatr Cardiol 1997; 6: 211-218.
142. Ino T, Akimoto K, Ohkubo M, Nishimoto K, Yabuta K, Takaya J, et al. Application of percutaneous transluminal coronary angioplasty to coronary arterial stenosis in Kawasaki disease. Circulation 1996; 93: 1709-1715.
143. Sugimura T, Yokoi H, Sato N, Akagi T, Kimura T, Iemura M, et al. Interventional treatment for children with severe coronary artery stenosis with calcification after long-term Kawasaki disease. Circulation 1997; 96: 3928-3933.
144. Kato H, Ichinose E, Yoshioka F, Takechi T, Matsunaga S, Suzuki K, et al. Fate of coronary aneurysms in Kawasaki disease: Serial coronary angiography and long-term followup study. Am J Cardiol 1982; 49: 1758-1766.
145. Tahara M, Waki C, Honda A, Shimozono A, Sato T. Comparative study of various methods of assessing Kawasaki disease-related stenotic lesions in coronary artery aneurysms: Ultrasonic cardiography, multi-detector row computed tomography, magnetic resonance imaging, coronary angiography, and intravascular ultrasonography. Japanese Journal of Pediatrics 2010; 63: 450-456 (in Japanese).
146. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease: A 10-to 21-year follow-up study of 594 patients. Circulation 1996; 94: 1379-1385.
147. Suzuki A, Kamiya T, Arakaki Y, Kinoshita Y, Kimura K. Fate of coronary arterial aneurysms in Kawasaki disease. Am J Cardiol 1994; 74: 822-824.
148. Iemura M, Ishii M, Sugimura T, Akagi T, Kato H. Long term consequences of regressed coronary aneurysms after Kawasaki disease: Vascular wall morphology and function. Heart 2000; 83: 307-311.
149. Suzuki A, Kamiya T, Ono Y, Okuno M, Yagihara T. Aortocoronary bypass surgery for coronary arterial lesions resulting from Kawasaki disease. J Pediatr 1990; 116: 567-573.
150. Fukuda T, Akagi T, Ishibashi M, Inoue O, Sugimura T, Kato H. Noninvasive evaluation of myocardial ischemia in Kawasaki disease: Comparison between dipyridamole stress thallium imaging and exercise stress testing. Am Heart J 1998; 135: 482-487.
151. Suzuki A, Kamiya T, Ono Y, Kinoshita Y, Kawamura S, Kimura K. Clinical significance of morphologic classification of coronary arterial segmental stenosis due to Kawasaki disease. Am J Cardiol 1993; 71: 1169-1173.
152. Ishii M, Ueno T, Akagi T, Baba K, Harada K, Hamaoka K, et al; Research Committee of Ministry of Health, Labour and Welfare--“Study of treatment and long-term management in Kawasaki disease”. Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease. Pediatr Int 2001; 43: 558-562.
153. Ishii M, Ueno T, Ikeda H, Iemura M, Sugimura T, Furui J, et al. Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease: Quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation 2002; 105: 3004-3010.
154. Takahashi K, Hirota A, Naoe S, Tsukada T, Masuda H, Tanaka N. A morphological study of intimal thickening in sequelae of coronary arterial lesions of Kawasaki disease (1). The Journal of Japanese College of Angiology 1991; 31: 17-25 (in Japanese).
155. Guidelines for Diagnosis and Treatment of Cardiovascular Diseases (1998-1999 Joint Working Groups Report). Guidelines for Secondary Prevention of Myocardial Infarction. Jpn Circ J 2000; 64 (Suppl. 4): 1081-1127 (in Japanese).
156. Ogawa S, Fukazawa R, Kamisago M, Uchikoba Y, Ikegam E, Watanabe M, et al. Angiotensin ii type 1 receptor blockers inhibit significant coronary stenosis in patients with coronary aneurysm after Kawasaki disease. Circulation 2004; 110 (Suppl): 707.
157. Li Z, Iwai M, Wu L, Liu HW, Chen R, Jinno T, et al. Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis. Hypertension 2004; 44: 758-763.
158. Yamada K, Fukumoto T, Shinkai A, Shirahata A, Meguro T. The platelet functions in acute febrile mucocutaneous lymph node syndrome and a trial of prevention for thrombosis by antiplatelet agent. Nihon Ketsueki Gakkai Zasshi 1978; 41: 791-802.
159. Shirahata A, Nakamura T, Ariyoshi N. Blood coagulation status in patients beyond 1 year after the onset of Kawasaki disease. J Jpn Pediatr Soc 1990; 94: 2608-2613 (in Japanese).
160. Shirahata A, Nakamura T, Asakura A. Optimal aspirin therapy for Kawasaki disease: Discussion of antithrombotic therapy. J Jpn Pediatr Soc 1985; 89: 2207-2214 (in Japanese).
161. Deleted in proof.
162. Onouchi Z, Hamaoka K, Sakata K, Ozawa S, Shiraishi I, Itoi T, et al. Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: Comparison of therapeutic regimens. Circ J 2005; 69: 265-272.
163. Suzuki A, Kamiya T, Ono Y, Kinoshita Y. Thrombolysis in the treatment of patients with Kawasaki disease. Cardiol Young 1993; 3: 207-215.
164. Tsuda E, Yasuda T, Naito H. Vasospastic angina in Kawasaki disease. J Cardiol 2008; 51: 65-69.
165. Flynn JT. Pediatric use of antihypertensive medications: Much more to learn. Curr Ther Res Clin Exp 2001; 62: 314-328.
166. Sugimura T, Kato H, Inoue O, Takagi J, Fukuda T, Sato N. Vasodilatory response of the coronary arteries after Kawasaki disease: Evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr 1992; 121: 684-688.
167. Ishikita T, Umezawa T, Saji T, Matsuo N, Yabe Y. Functional abnormality of coronary arteries in children after Kawasaki disease: Distensibility of coronary arterial wall by isosorbide dinitrate. Ped Cardiol Card Surg 1992; 8: 265-270 (in Japanese).
168. Guidelines for Diagnosis and Treatment of Cardiovascular Diseases (2009 Joint Working Groups Report). Guidelines for Diagnostic Evaluation of Patients with Chronic Ischemic Heart Disease (JCS 2010). http://www.j-circ.or.jp/guideline/pdf/JCS2010_yamagishi_h.pdf (in Japanese) (available January 2013).
169. Guidelines for Diagnosis and Treatment of Cardiovascular Diseases (2008 Joint Working Groups Report). Guidelines for management of anticoagulant and antiplatelet therapy in cardiovascular disease (JCS 2009). http://www.j-circ.or.jp/guideline/pdf/JCS2009_hori_h.pdf (in Japanese) (available January 2013).
170. Guidelines for Diagnosis and Treatment of Cardiovascular Diseases (2005 Joint Working Groups Report). Guidelines for the primary prevention of ischemic heart disease revised version (JCS 2006). http://www.j-circ.or.jp/guideline/pdf/JCS2006_kitabatake_h.pdf (in Japanese) (available January 2013).
171. Guidelines for Diagnosis and Treatment of Cardiovascular Diseases (2006 Joint Working Groups Report). Guidelines for Management of Acute Coronary Syndrome without Persistent ST Segment Elevation (JCS 2007). http://www.j-circ.or.jp/guideline/pdf/JCS2007_yamaguchi_h.pdf (in Japanese) (available January 2013).
172. Guidelines for Diagnosis and Treatment of Cardiovascular Diseases (2009 Joint Working Groups Report). Guidelines for Treatment of Chronic Heart Failure (JCS 2010). http://www.j-circ.or.jp/guideline/pdf/JCS2010_matsuzaki_h.pdf (in Japanese) (available January 2013).
173. Guidelines for Diagnosis and Treatment of Cardiovascular Diseases (2010 Joint Working Groups Report). Guidelines for Treatment of Acute Heart Failure (JCS 2011). http://www.j-circ.or.jp/guideline/pdf/JCS2011_izumi_h.pdf (in Japanese) (available January 2013).
174. Scientific Committee for the Japanese Society of Pediatric Cardiology and Cardiac Surgery. Guidelines for pharmacotherapy of heart failure in children. Ped Cardiol Card Surg 2001; 17: 501-512 (in Japanese).
175. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110: 2747-2771.
176. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006; 113: 2363-2372.
177. Monagle P, Chalmers E, Chan A, DeVeber G, Kirkham F, Massicotte P, et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (Suppl 6): 887S-968S. 177a. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB 3rd, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006; 113: e166-e286, doi:10.1161/CIRCULATIONAHA. 106.173220.
178. Kato H, Inoue O, Ichinose E, Akagi T, Sato N. Intracoronary urokinase in Kawasaki disease: Treatment and prevention of myocardial infarction. Acta Paediatr Jpn 1991; 33: 27-35.
179. Nakagawa M, Watanabe N, Okuno M, Okamoto N, Fujino H. Effects of intracoronary tissue-type plasminogen activator treatment in Kawasaki disease and acute myocardial infarction. Cardiology 2000; 94: 52-57.
180. Shiraishi J, Sawada T, Tatsumi T, Azuma A, Nakagawa M. Acute myocardial infarction due to a regressed giant coronary aneurysm as possible sequela of Kawasaki disease. J Invasive Cardiol 2001; 13: 569-572.
181. Tsubata S, Ichida F, Hamamichi Y, Miyazaki A, Hashimoto I, Okada T. Successful thrombolytic therapy using tissue-type plasminogen activator in Kawasaki disease. Pediatr Cardiol 1995; 16: 186-189.
182. Sato Y, Nishi T. A case of acute myocardial infarction developing following Kawasaki disease in whom PTCR·PTCA proved effective. Ped Cardiol Card Surg 1996; 12: 777-782 (in Japanese).
183. Ohkubo M, Ino T, Shimazaki S, Akimoto K, Nishimoto K, Matsubara K, et al. Successful percutaneous transluminal coronary recanalization with tissue plasminogen activator in Kawasaki disease. J Jpn Pediatr Soc 1994; 98: 1758-1765 (in Japanese).
184. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI). Lancet 1986; 1: 397-402.
185. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988; 2: 349-360.
186. Guidelines for Diagnosis and Treatment of Cardiovascular Diseases (2006-2007 Joint Working Groups Report). Guidelines for the management of patients with ST-elevation myocardial infarction (JCS 2008). Circ J 2008; 72 (Suppl. 4): 1347-1464 (in Japanese).
187. Ino T, Nishimoto K, Akimoto K, Park I, Shimazaki S, Yabuta K, et al. Percutaneous transluminal coronary angioplasty for Kawasaki disease: A case report and literature review. Pediatr Cardiol 1991; 12: 33-35.
188. Satler LF, Leon MB, Kent KM, Pichard AD, Martin GR. Angioplasty in a child with Kawasaki disease. Am Heart J 1992; 124: 216-219.
189. Nishimura H, Sawada T, Azuma A, Kohno Y, Katsume H, Nakagawa M, et al. Percutaneous transluminal coronary angioplasty in a patient with Kawasaki disease: A case report of an unsuccessful angioplasty. Jpn Heart J 1992; 33: 869-873.
190. Kawata T, Hasegawa J, Yoshida Y, Yoshikawa Y, Kawachi K, Kitamura S. Percutaneous transluminal coronary angioplasty of the left internal thoracic artery graft: A case report in a child. Cathet Cardiovasc Diagn 1994; 32: 340-342.
191. Hijazi ZM, Smith JJ, Fulton DR. Stent implantation for coronary artery stenosis after Kawasaki disease. J Invasive Cardiol 1997; 9: 534-536.
192. Hijazi ZM. Coronary arterial stenosis after Kawasaki disease: Role of catheter intervention. Catheter Cardiovasc Interv 1999; 46: 337.
193. Ueno T, Kai H, Ikeda H, Ichiki K, Hashino T, Imaizumi T. Coronary stent deployment in a young adult with Kawasaki disease and recurrent myocardial infarction. Clin Cardiol 1999; 22: 147-149.
194. Hashmi A, Lazzam C, McCrindle BW, Benson LN. Stenting of coronary artery stenosis in Kawasaki disease. Catheter Cardiovasc Interv 1999; 46: 333-336.
195. Akagi T, Ogawa S, Ino T, Iwasa M, Echigo S, Kishida K, et al. Catheter interventional treatment in Kawasaki disease: A report from the Japanese Pediatric Interventional Cardiology Investigation group. J Pediatr 2000; 137: 181-186.
196. Misumi K, Taniguchi Y. The 34th Kinki-district meeting on Kawasaki disease: Cardiologists’ view of coronary lesions and coronary events associated with Kawasaki disease: On current practices of cardiac intervention with rotablators, excimer laser angioplasty, and drug-eluting stents. Prog Med 2010; 30: 1899-1904 (in Japanese).
197. Kato H, Ishii M, Akagi T, Eto G, Iemura M, Tsutsumi T, et al. Interventional catheterization in Kawasaki disease. J Interv Cardiol 1998; 11: 355-361.
198. Oda H, Miida T, Ochiai Y, Toeda T, Higuma N, Ito E. Successful stent implantation in acute myocardial infarction and successful directional coronary atherectomy of a stenotic lesion involving an aneurysm in a woman with Kawasaki disease of adult onset. J Interv Cardiol 1997; 10: 375-380.
199. Miyazaki A, Tsuda E, Miyazaki S, Kitamura S, Tomita H, Echigo S. Percutaneous transluminal coronary angioplasty for anastomotic stenosis after coronary arterial bypass grafting in Kawasaki disease. Cardiol Young 2003; 13: 284-289.
200. Tsuda E, Miyazaki S, Takamuro M, Fuse S, Tsuji Y, Echigo S. Strategy for localized stenosis caused by Kawasaki disease: Midterm results of percutaneous transluminal coronary balloon angioplasty in two infants. Pediatr Cardiol 2006; 27: 272-275.
201. Tsuda E, Miyazaki S, Yamada O, Takamuro M, Takekawa T, Echigo S. Percutaneous transluminal coronary rotational atherectomy for localized stenosis caused by Kawasaki disease. Pediatr Cardiol 2006; 27: 447-453.
202. Muta H, Ishii M. Percutaneous coronary intervention versus coronary artery bypass grafting for stenotic lesions after Kawasaki disease. J Pediatr 2010; 157: 120-126.
203. Ariyoshi M, Shiraishi J, Kimura M, Matsui A, Takeda M, Arihara M, et al. Primary percutaneous coronary intervention for acute myocardial infarction due to possible sequelae of Kawasaki disease in young adults: A case series. Heart Vessels 2011; 26: 117-124.
204. Kitamura S, Kawachi K, Oyama C, Miyagi Y, Morita R, Koh Y, et al. Severe Kawasaki heart disease treated with an internal mammary artery graft in pediatric patients: A first successful report. J Thorac Cardiovasc Surg 1985; 89: 860-866.
205. D’ Amico TA, Sabiston DC. Kawasaki’s disease. In: Surgery of the chest. Sabiston DC, Spencer FC, editors. Philadelphia: Saunders, 1990: 1759-1766.
206. Mavroudis C, Backer CL, Muster AJ, Pahl E, Sanders JH, Zales VR, et al. Expanding indications for pediatric coronary artery bypass. J Thorac Cardiovasc Surg 1996; 111: 181-189.
207. Kitamura S, Tsuda E, Wakisaka Y. Pediatric coronary artery bypass grafting for Kawasaki disease: 20-years’ outcome. Japanese Journal of Clinical Medicine 2008; 66: 380-386 (in Japanese).
208. Tsuda E, Kitamura S, Kimura K, Kobayashi J, Miyazaki S, Echigo S, et al. Long-term patency of internal thoracic artery grafts for coronary artery stenosis due to Kawasaki disease: Comparison of early with recent results in small children. Am Heart J 2007; 153: 995-1000.
209. Kitamura S, Kawasaki T, Kato H, Asai T, Yanagawa H, Hamashima Y, et al. Surgical treatment subcommittee for the Ministry of Health and Welfare research project on mental and physical disorders. Research on disorders of unknown cause in infants and young children, Book 2: Study on Kawasaki disease. A study report in 1985. 1986: 39-42 (in Japanese).
210. Tsuda E, Kitamura S; Cooperative Study Group of Japan. National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation 2004; 110: II61-II66.
211. Yamauchi H, Ochi M, Akaishi J, Ohmori H, Hinokiyama K, Saji Y, et al. Surgical therapy in patients with giant coronary artery aneurysms due to Kawasaki disease. Ped Cardiol Card Surg 2004; 20: 94-99 (in Japanese).
212. Ozkan S, Saritas B, Aslim E, Akay TH, Aslamaci S. Coronary bypass surgery in Kawasaki disease in a four-year-old patient: Case report. J Card Surg 2007; 22: 511-513.
213. Kitamura S, Seki T, Kawachi K, Morita R, Kawata T, Mizuguchi K, et al. Excellent patency and growth potential of internal mammary artery grafts in pediatric coronary artery bypass surgery. New evidence for a “live” conduit. Circulation 1988; 78: I129-I139.
214. Kitamura S, Kawachi K, Seki T, Morita R, Nishii T, Mizuguchi K, et al. Bilateral internal mammary artery grafts for coronary artery bypass operations in children. J Thorac Cardiovasc Surg 1990; 99: 708-715.
215. Takeuchi Y, Gomi A, Okamura Y, Mori H, Nagashima M. Coronary revascularization in a child with Kawasaki disease: Use of right gastroepiploic artery. Ann Thorac Surg 1990; 50: 294-296.
216. Kitamura S. Surgical management for cardiovascular lesions in Kawasaki disease. Cardiol Young 1991; 1: 240-253.
217. Kitamura S, Tsuda E, Kobayashi J, Nakajima H, Yoshikawa Y, Yagihara T, et al. Twenty-five-year outcome of pediatric coronary artery bypass surgery for Kawasaki disease. Circulation 2009; 120: 60-68.
218. Fukazawa R, Ikegam E, Watanabe M, Hajikano M, Kamisago M, Katsube Y, et al. Coronary artery aneurysm induced by Kawasaki disease in children show features typical senescence. Circ J 2007; 71: 709-715.
219. Kuramochi Y, Ohkubo T, Takechi N, Fukumi D, Uchikoba Y, Ogawa S. Hemodynamic factors of thrombus formation in coronary aneurysms associated with Kawasaki disease. Pediatr Int 2000; 42: 470-475.
220. Ogawa S. Issues in healthcare in adults: Current medical and surgical treatment of cardiovascular sequelae of Kawasaki disease. Yamabiko Tsushin 2006; 142: 2-7 (in Japanese).
221. Kitamura S, Kawashima Y, Kawachi K, Harima R, Ihara K, Nakano S, et al. Severe mitral regurgitation due to coronary arteritis of mucocutaneous lymph node syndrome: A new surgical entity. J Thorac Cardiovasc Surg 1980; 80: 629-636.
222. Endo M. Surgical treatment of Kawasaki disease in the future. Prog Med 1991; 11: 97-99 (in Japanese).
223. Travaline JM, Hamilton SM, Ringel RE, Laschinger JC, Ziskind AA. Cardiac transplantation for giant coronary artery aneurysms complicating Kawasaki disease. Am J Cardiol 1991; 68: 560-561.
224. Guide for the use of the School Activity Management Table for Children with Heart Disease; Guide for the use of the School Activity Management Table for Children with Renal Disease-For schools and school physicians, the 2011 revision. The Japanese Society of School Health. 2013: 3-11 (in Japanese).
225. School Cardiac Screening Study Committee for the Japanese Society of Pediatric Cardiology and Cardiac Surgery. Guidelines for management of arrhythmia with no underling diseases, the 2002 revision. Ped Cardiol Card Surg 2002; 18: 610-611 (in Japanese).
226. Sonobe T. Practice of immunization: High-dose gamma-globulin therapy and immunization. Japanese Journal of Pediatric Medicine 1994; 26: 1929-1933 (in Japanese).
227. Tsuda E, Kamiya T, Kimura K, Ono Y, Echigo S. Coronary artery dilatation exceeding 4.0 mm during acute Kawasaki disease predicts a high probability of subsequent late intima-medial thickening. Pediatr Cardiol 2002; 23: 9-14.
228. Kurotobi S, Nagai T, Kawakami N, Sano T. Coronary diameter in normal infants, children and patients with Kawasaki disease. Pediatr Int 2002; 44: 1-4.
229. de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 1998; 133: 254-258.
230. Akagi T, Rose V, Benson LN, Newman A, Freedom RM. Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr 1992; 121: 689-694.
231. Tsuda E, Kamiya T, Ono Y, Kimura K, Kurosaki K, Echigo S. Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diameter during Kawasaki disease. Pediatr Cardiol 2005; 26: 73-79.
232. Suzuki A. Long-term prognosis of coronary artery disorder. In: Kamiya T, editor. Diagnosis and treatment of Kawasaki disease: With special emphasis on cardiovascular disorders. Osaka: Nippon Rinsho Sha, 1994; 266-275 (in Japanese).
233. Ogino H. Introduction of the Kawasaki disease patient card-Development of the “acute phase Kawasaki disease in summary” supervised by the Japan Kawasaki Disease Research Society. Prog Med 2003; 23: 1806-1811 (in Japanese).
234. Kaichi S, Tsuda E, Fujita H, Kurosaki K, Tanaka R, Naito H, et al. Acute coronary artery dilation due to Kawasaki disease and subsequent late calcification as detected by electron beam computed tomography. Pediatr Cardiol 2008; 29: 568-573.
235. Shinohara T. Clinical study of dorp out cases in Kawasaki disease with cardiovascular lesions. Proceedings for the 32nd meeting of the Japanese Society of Kawasaki Disease. 2012: 86 (in Japanese).
236. Abe O, Sumitomo N, Kamiyama H, Nakajima S, Kawamura K, Watanabe H, et al. Investigation neglecting medical examination among Kawasaki Disease with reference myocardial perfusion imaging. Proceedings for the 32nd meeting of the Japanese Society of Kawasaki Disease. 2012: 88 (in Japanese).
237. Gordon JB, Kahn AM, Burns JC. When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood. J Am Coll Cardiol 2009; 54: 1911-1920.
238. Imakita M, Yutani C, Strong JP, Sakurai I, Sumiyoshi A, Watanabe T, et al. Second nation-wide study of atherosclerosis in infants, children and young adults in Japan. Atherosclerosis 2001; 155: 487-497.
239. Sakata K, Onouchi Z. Plasma Thrombomodulin levels in patients with Kawasaki disease in long-term periods. J Jpn Pediatr Soc 1993; 97: 93-96 (in Japanese).
240. Dhillon R, Clarkson P, Donald AE, Powe AJ, Nash M, Novelli V, et al. Endothelial dysfunction late after Kawasaki disease. Circulation 1996; 94: 2103-2106.
241. Niboshi A, Hamaoka K, Sakata K, Yamaguchi N. Endothelial dysfunction in adult patients with a history of Kawasaki disease. Eur J Pediatr 2008; 167: 189-196.
242. Schober A, Zernecke A. Chemokines in vascular remodeling. Thromb Haemost 2007; 97: 730-737.
243. Suzuki A, Tsuda E, Fujiwara M, Arakaki Y, Onn Y, Kamiya T. Intravascular echographic findings of artery lesions of remotephase Kawasaki disease. Prog Med 1996; 16: 1797-1800 (in Japanese).
244. Vliegenthart R, Hollander M, Breteler MM, van der Kuip DA, Hofman A, Oudkerk M, et al. Stroke is associated with coronary calcification as detected by electron-beam CT: The Rotterdam Coronary Calcification Study. Stroke 2002; 33: 462-465.
245. Kondos GT, Hoff JA, Sevrukov A, Daviglus ML, Garside DB, Devries SS, et al. Electron-beam tomography coronary artery calcium and cardiac events: A 37-month follow-up of 5635 initially asymptomatic low-to intermediate-risk adults. Circulation 2003; 107: 2571-2576.
246. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-126.
247. Gaenzer H, Neumayr G, Marschang P, Sturm W, Kirchmair R, Patsch JR. Flow-mediated vasodilation of the femoral and brachial artery induced by exercise in healthy nonsmoking and smoking men. J Am Coll Cardiol 2001; 38: 1313-1319.
248. Liu Y, Onouchi Z, Sakata K, Ikuta K. An experimental study on the role of smooth muscle cells in the pathogenesis of atherosclerosis of the coronary arteritis. J Jpn Pediatr Soc 1996; 100: 1453-1458 (in Japanese).
249. Ohni S, Goto S, Nakamura H, Yamada T, Hirano M, Sakurai I. Adult multiple coronary aneurysms of Kawasaki’s disease’s sequelae Two autopsy cases. The Official Journal of Japanese Society of Laboratory Medicine 1998; 46: 177-181 (in Japanese).
250. Suda K, Iemura M, Nishiono H, Teramachi Y, Koteda Y, Kishimoto S, et al. Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: A single-institution experience. Circulation 2011; 123: 1836-1842.
251. Tsuda E, Hirata T, Matsuo O, Abe T, Sugiyama H, Yamada O. The 30-year outcome for patients after myocardial infarction due to coronary artery lesions caused by Kawasaki disease. Pediatr Cardiol 2011; 32: 176-182.
252. Daniels LB, Tjajadi MS, Walford HH, Jimenez-Fernandez S, Trofimenko V, Fick DB Jr, et al. Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia. Circulation 2012; 125: 2447-2453.
253. Tsuda E. Pregnancy and delivery in patients with a history of Kawasaki disease. Cardioangiology 2011; 69: 341-345 (in Japanese).
254. De Wilde JP, Rivers AW, Price DL. A review of the current use of magnetic resonance imaging in pregnancy and safety implications for the fetus. Prog Biophys Mol Biol 2005; 87: 335-353.
255. Nolan TE, Savage RW. Peripartum myocardial infarction from presumed Kawasaki’s disease. South Med J 1990; 83: 1360-1361.
256. Tsuda E, Kawamata K, Neki R, Echigo S, Chiba Y. Nationwide survey of pregnancy and delivery in patients with coronary arterial lesions caused by Kawasaki disease in Japan. Cardiol Young 2006; 16: 173-178.
257. Perloff JK, Koos B. Pregnancy and congenital heart disease: The mother and the fetus. In: Perloff JK, Child JS, editors. Congenital heart disease in adults. 2nd edn. Philadelphia: W.B. Saunders, 1998; 144-164.
258. Guidelines for Diagnosis and Treatment of Cardiovascular Diseases (2009 Joint Working Groups Report). Guidelines for Indication and Management of Pregnancy and Delivery in Women with Heart Disease (JCS 2010). http://www.j-circ.or.jp/guideline/pdf/JCS2010niwa.h.pdf (in Japanese) (available January 2013).
259. Chong MK, Harvey D, de Swiet M. Follow-up study of children whose mothers were treated with warfarin during pregnancy. Br J Obstet Gynaecol 1984; 91: 1070-1073.
260. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999; 33: 1637-1641.
261. Arakawa K, Akita T, Nishizawa K, Kurita A, Nakamura H, Yoshida T, et al. Anticoagulant therapy during successful pregnancy and delivery in a Kawasaki disease patient with coronary aneurysm: A case report. Jpn Circ J 1997; 61: 197-200.
262. Buttar HS. An overview of the influence of ACE inhibitors on fetalplacental circulation and perinatal development. Mol Cell Biochem 1997; 176: 61-71.
263. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006; 354: 2443-2451.
264. Badui E, Valdespino A, Lepe L, Rangel A, Campos A, Leon F. Acute myocardial infarction with normal coronary arteries in a patient with dermatomyositis. Case report. Angiology 1996; 47: 815-818.
265. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 3147-3197.
266. Pongratz G, Gansser R, Bachmann K, Singer H, Worth H. Myocardial infarction in an adult resulting from coronary aneurysms previously documented in childhood after an acute episode of Kawasaki’s disease. Eur Heart J 1994; 15: 1002-1004.
267. Fujiwara H. Sequelae of Kawasaki disease in adults. In: Kawasaki T, Hamashima Y, Kato H, Shigematsu I, Yanagawa H, editors. Kawasaki disease. Tokyo: Nankodo Co., Ltd., 1988; 235-240 (in Japanese).